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ABSTRACT
Intrarenal changes in cytoplasmic calcium levels have a key role in determining pathologic and pharmacologic
responses inmajor kidney diseases.However, cell-specific delivery of calcium-sensitive probes in vivo remains
problematic. We generated a transgenic rat stably expressing the green fluorescent protein-calmodulin–
based genetically encoded calcium indicator (GCaMP2) predominantly in the kidney proximal tubules. The
transposon-basedmethod used allowed the generation of homozygous transgenic rats containing one copy
of the transgene per allele with a defined insertion pattern, without genetic or phenotypic alterations. We
applied in vitro confocal and in vivo two-photon microscopy to examine basal calcium levels and ligand- and
drug-induced alterations in these levels in proximal tubular epithelial cells. Notably, renal ischemia induced a
transient increase in cellular calcium, and reperfusion resulted in a secondary calcium load, which was signif-
icantly decreased by systemic administration of specific blockers of the angiotensin receptor and the Na-Ca
exchanger. The parallel examination of in vivo cellular calcium dynamics and renal circulation by fluorescent
probes opens new possibilities for physiologic and pharmacologic investigations.
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The mammalian kidney is a highly complex organ,
and physiologic and pharmacologic modulation of
intrarenal calcium homeostasis has hardly been
explored yet.1–3 Proximal tubular epithelial (PTE)
cells are among the cell types most sensitive to ische-
mia and nephrotoxicity. Cellular calcium changes are
key players in these responses; thus, exploration of
cellular mechanisms underlying the pathophysiology
of kidney injuries would have an utmost importance
in drug development and the treatment of kidney
diseases. Calcium-dependent mechanisms in ische-
mia-reperfusion lead in many cases to irreversible
cellular damage.4,5 Therefore, a better understanding
of these mechanisms is essential to improve outcome
for kidney transplantations.
In vivo cellular calcium dynamics studies are
greatly hindered by the difficulty of delivering
calcium-sensitive probes to specific cells. This
problemmay be avoided by a targeted, stable expres-
sion of fluorescent sensor protein chimeras, enabling
quantitative evaluation of cellular calcium dynamics.
Recent developments in two-photon microscopy, al-
lowing analysis of rapid changes of different fluores-
cence intensities relatively deep in living tissues,
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opened the possibility of performing in vivo studies for calcium
dynamics in themammalian kidney.6–8 Preferential use of rats in
pharmacokinetic and pharmacodynamic studies emphasizes the
importance of calcium monitoring in tissues of this model an-
imal. To explore renal calcium dynamics, we have generated TG
rats stably expressing a calcium indicator protein predominantly
in kidney proximal tubules (PTs), and we used fluorescence mi-
croscopy to study changes in renal intracellular calcium levels.
For efficient insertion of the transgene reporter construct
into rat zygotes, we have used the hyperactive Sleeping Beauty
transposon. This approach promoted the generation of TG rat
founders at high frequencies9 and allowed selection of homo-
zygous TG rats, which contained one copy/allele of the trans-
gene with a defined insertion pattern, with nomajor genetic or
phenotypic alterations (see Concise Methods).
For the intracellular fluorescent calcium indicator, we
applied the genetically encoded calcium indicator (GCaMP2)
construct, a genetically engineered calmodulin-based calcium
sensor fused to a green fluorescent protein (GFP)–based fluo-
rescent protein.10 Changes in light intensity emitted by this
fluorescent protein can be directly used to determine changes
in intracellular free calcium concentration. The GCaMP2 pro-
tein has already been applied in various in vivo measurements
within selected tissue preparations and in transgenic mice.11–14
Although new versions of genetically engineered calcium indi-
cators are also available, the GCaMP2 construct was reliably and
efficiently working in our hands in various mammalian cellular
systems. As reported,15 in human stem cells calcium imaging
could be performed without the need for potentially toxic dye
loading.
In TG rats, the GCaMP2 calcium indicator expression was
driven by a CAG promoter, which we previously applied for
generating a calcium reporter system in human embryonic
stem cells.16 In TG rats we found especially high GCaMP2
expression in renal PTE cells. For in vitro imaging we applied
confocal microscopy, while for in vivo studies we used two-
photon microscopy with multicolor detection and rapid re-
sponse software capabilities (see Concise Methods).
RESULTS
GCaMP2 Expression in Kidney PT Cells: In Vitro
Confocal Microscopy Experiments
Kidneys of rats stably expressing the GCaMP2 indicator protein
were examined by preparing frozen tissue slices and by establish-
ing long-term cultures of dissociated cell types. In these prepa-
rations we examined GCaMP2 expression by anti-GFP antibody
staining to bypass calcium-level dependent heterogeneity of the
GCaMP2 signal.
In frozen, fixed, and immunostained kidney sections, a
relatively homogenous, high level GCaMP2 staining was found
in PTE cells (Figure 1, A and B). This localization was also re-
inforced by costaining with (g-glutamyltranspeptidase 1
(GGT11), a marker of PTE cells (Figure 1C). As shown in
immunostained kidney sections (Figure 1, B and C, Supplemen-
tal Figure 1, A and B), expression of both GCaMP2 and GGT1
was much lower in the glomeruli, the distal and collecting tu-
bules, or the vascular tissues.
In immunostaining of isolated cultures of PTE cells, the
GCaMP2expressioncolocalizedwithmarkersof thePTepithelia,
documented here byGGT1 costaining (Figure 1,D–F). PTE cells
stained positive for ATP binding cassette transporter G2, a PTE
marker (Supplemental Figure 1, D and E).
Inthefollowingexperimentsfluorescence intensitychangesof
GCaMP2 were characterized in cultured PTE cells. As shown in
Figure 2 and Supplemental Figure 2, addition of ATP, angioten-
sin II (AngII), trypsin, adrenaline, or histamine significantly
increased cellular free calcium levels. At the end of each exper-
iment we calibrated the calcium response by 5 mM ionomycin,
producing maximum cellular calcium load, followed by the ad-
dition of excess EGTA, decreasing intracellular calcium to the
minimum. We found that calcium release from PTE cells in
calcium-free medium by the addition of the sarcoplasmic/
endoplasmic reticulum Ca(2+)–dependent ATPase pump in-
hibitor thapsigargin+ATP induced a major calcium-induced
calcium influx (Supplementary Figure 2D).
As shown in Figure 2, A and B, addition of ATP (5–100 mM)
produced a large increase in intracellular free calcium in PTE
cells. A second ATP addition had no such effect (Supplemental
Figure 2E), and pretreatment of the cells with suramin (200–600
mM), a P2 purinergic receptor inhibitor, eliminated ATP-
induced calciumsignal (Figure 2,AandB).Thesefindings indicate
calcium signaling through P2 purinergic receptors in PTE cells.
We found that AngII (10mM) induced ameasurable calcium
signal in isolated PTE cells, although the amplitude of calcium
transients detected in individual cells showed high diversity (Fig-
ure 2C). RepeatedAngII addition did not cause repeated calcium
effects, and the specific inhibitor of angiotensin receptor type 1
(AT1), active form of candesartan (1 mM),17 fully blocked
AngII-induced calcium response (not shown).
In various kidney diseases and in the process of kidney
transplantation, ischemia and reperfusion cause substantial
damage in the PTs, especially by changing calcium homeostasis.3
In an attempt to mimic ischemia (hypoxia) and reperfusion
(reoxygenation) in isolated renal PTE cells, we have pretreated
the cells in media containing 200 mM CoCl2, reported to cause
hypoxic conditions in various cell types in vitro.18,19 After 24
hours’ pretreatment, exchange of the media for oxygenated me-
dia containing no CoCl2 resulted in a large transient increase in
cellular calcium levels, while addition of ATP still produced a
rapid calcium rise (Figure 2D). The exchange of media without
CoCl2 pretreatment did not alter intracellular calcium levels
(Supplemental Figure 2F).
Because data in the literature indicate that reperfusion
may cause a large calcium influx in renal PTE cells because of
the reverse operation of the Na-Ca exchanger (NCX),20,21
we tested the effect of a powerful inhibitor of the NCX, KB-
R7943,22 on this process. As shown in Figure 2E, addition of
KB-R7943 in CoCl2-pretreated PTE cells slightly increased the
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basal calcium levels while eliminating the rise in calcium due
to reoxygenation.
In Vivo Two-Photon Microscopy Studies of Changes in
Renal Proximal Tubular Cell Calcium and Kidney Blood
Flow
In these experiments we examined calcium alterations in the rat
kidney PTs by using two-photon microscopy (see Concise
Methods). For examining renal blood flow and cellular calcium
changes simultaneously, intraarterial injection of a 70-kDa large-
molecule rhodamine-dextranconjugate (RDC)wasapplied.This
material is preferentially retained in the renal blood circulation,
but slow filtration and tubular passage can also be followed.1,23
For two-photon imaging of cortical areas containing mostly PTs
(Supplemental Figure 3, A and B), or deeper regions containing
glomeruli and other tubular structures (Supplemental Figure 3,
C and D, Supplemental Video 1) were selected.
Figure 3A shows the renal PT baseline intracellular calcium
levels visualized by GCaMP2 fluorescence, in relatively large
kidney cortex areas. Of note, despite the
relatively homogeneous GCaMP2 expres-
sion in the PTs (Figure 1), different PTareas
showed different GCaMP2 fluorescence.
To assessPTregions connectedwithinone
nephron, we followed the low-level appear-
ance of the circulating RDC in the tubular
structures. As shown in Supplemental Figure
4, A and B, and Supplemental Video 2, the
movement of the intratubularly-appearing
RDC filtrate indicated tubular areas belong-
ing to one nephron.
In PTE cells a spontaneous calcium-
dependent fluorescence oscillation was
observed. As shown in Figure 3B and in
Supplemental Video 3, in neighboring PTE
cells this calcium oscillation had a variable
frequency, between 3 and 10mHz. Thus, this
oscillation was probably not caused by some
artificial effect (such as the animal’s heart-
beat or breathing or external noise) but
rather represents an inherent calcium oscil-
lation in PTE cells.
In the following experiments we studied
the in vivo effects of potential ligands and
inhibitors. Figure 4, A and B, showGCaMP2
fluorescence changes following intraarterial
addition of 3.25 mg/kg ATP (a final blood
concentration of about 100 mM). ATP
induced a rapid, high-level increase in PT
cellular calcium, which required several
minutes to return to the baseline levels. This
ATP-induced calcium wave could be signifi-
cantly reduced by a 5-minute pretreatment
of suramin (25 mg/kg; final blood concen-
tration, approximately 300 mM), which in
itself had nomeasurable effect on PT calcium levels. The admin-
istration of ATP caused a receptor desensitization, in which no
effect was observed after a second addition of ATP (Supplemen-
tal Figure 5).
Figure 4, C and D, show the in vivo effect of intraarterial
addition of AngII onPT cellular calcium levels. As shown,AngII,
50 mg/kg (about 0.75 mM final blood concentration), caused a
major, rapid increase in PT cellular calcium,whichwas declining
to a baseline level within several minutes. Short pretreatment
with 1 mM (28 mg/kg) candesartan eliminated AngII-induced
calcium response, while irregular fluctuations in baseline cal-
cium levels were detected.
To evoke in vivo experimental renal ischemia-reperfusion,
kidney vessels were clamped in anesthetized animals; after 30
minutes clamps were carefully removed to allow the restoration
of renal blood flow. Similar experiments were also performed in
the presence of the rhodamine-dextran in the circulating blood
(this did not significantly affect calcium signals). After the ex-
periments animals were euthanized and the renal PT cellular
Figure 1. GCaMP2 is expressed mainly in the kidney proximal tubules (PT). Character-
ization of GCaMP2 and expression of the PTE marker GGT1 by immunostaining in the
transgenic rat kidney tissue slices (A–C) and in dissociated, cultured renal proximal tubular
cells (D–F). Anti-GFP (green) and anti-CGT1 (red) immunostainings and nuclear DNA
staining with Hoechst 33342 or DAPI (blue) are visualized in the panels. (A) GCaMP2
expression in PTs of the transgenic rat kidney visualized by GFP immunostaining (lon-
gitudinal section). (B) GCaMP2 expression in a horizontal section of transgenic rat kidney
visualized by anti-GFP immunostaining and nuclear DNA staining. The PTs show a much
higher level of GFP staining than other tubular structures or the glomeruli. (C) GGT1
expression in transgenic rat kidney in the same horizontal section as in B. GGT1 staining
for PT epithelia closely correspond to GCaMP2 expression. (D) GCaMP2 expression in
dissociated and cultured renal proximal tubular cells of transgenic rats. (E) GGT1 ex-
pression in dissociated and cultured renal proximal tubular cells of transgenic rats (the
same slide area as in D), visualized by GGT1 immunostaining. (F) Colocalization of
GCaMP2 and GGT1 in cultured renal proximal tubular cells.
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Figure 2. GCaMP2 reveals ATP, AngII, and experimental hypoxia/reoxygenation mediated calcium dynamics in isolated PTE cells and
shows that these effects can be inhibited by specific blockers. (A and B) Effects of ATP 100 mM without pretreatment (red line) and after
pretreatment with suramin 100 mM (yellow line) and 300 mM (blue line). (C) Effect of AngII 1 mM. (D and E) Effects of pretreatment with
CoCl2 100 mM for 24 hours on the calcium-dependent cellular fluorescence. (D) Effect of medium change (MC) to normal medium and
the addition of ATP (100 mM). (E) Effects of the addition of 300 nM KB-R7943, a specific inhibitor of the Na-Ca exchanger, followed by
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calcium levels increased to a maximum level, providing a cali-
bration possibility (Supplemental Figure 6).
These in vivo renal ischemia-reperfusion experiments re-
quired several repetitions, and representative experiments, per-
formed in at least three animals, are shown in Figure 5, A and B.
Clamping of the renal vessels induced a rapid increase in PT
cellular calcium levels, and a restoration of the cellular calcium
levels occurred during the following minutes. PT calcium con-
centrations usually reached the baseline calcium levels before the
endof the ischemic period (30minutes). After the removal of the
clamps, again a rapid, significant increase in the PT cellular cal-
cium levels was observed, which was also decreasing in time
(Figure 5, A–C). Thus, both ischemia and reperfusion evoked
major changes in PT cellular calcium.
In the following experiments we examined the effects of
various drugs on the PTE cell calcium changes during ischemia-
reperfusion. When the animals were pretreated with the AT1
inhibitor candesartan (1mM), the calciumpeak after renal blood
vessel clamping was similar to that in the controls, while the
second calcium wave, caused by reperfusion, was significantly
reduced (Figure 5A). Addition of the P2 receptor inhibitor suramin
before ischemia did not significantly affect the first or second
calcium peak in ischemia-reperfusion (Figure 5C).
Becausedata in the literature indicate that reperfusion in renal
PTEcellsmaycause a large calcium influxas a result of the reverse
operation of the NCX,20,21 we explored the effect of an efficient
inhibitor of this transporter, KB-R7943,22 on in vivo calcium
signals evoked by ischemia-reperfusion. This agent, at a dose
of 8.0 mg/kg (final blood concentration, approximately
300 nM) did not significantly affect the baseline PT calcium
levels (Figure 5B). However, the calcium peak evoked by ische-
mia was somewhat increased and prolonged, while the calcium
wave caused by reperfusion was practically absent.
DISCUSSION
The laboratory rat has long been the preferred animal model for
most physiology, pharmacology, and toxicology studies.
Recently a large number of rat strains have been developed as
experimentalmodels for specificdiseases. In thepresent studywe
established the first rat model expressing the GCaMP2 calcium
indicator protein at an exceptionally high level in kidney PTs. As
demonstratedhere, theGCaMP2canproperlybeused to study in
vivo kidney calcium physiology with relatively slow changes in
calcium levels. However, the genetically encoded calcium indi-
cator technology is developing rapidly, and GCaMP indicators
with higher fluorescence yield and greater dynamic range are
now available. These indicators reliably detect rapid calcium
transients in various neural cell types in vivo.24–26 Using cultured
PTE cells, we performed in vitro confocal microscopy studies;
using two-photonmicroscopy, we examined the in vivo calcium
modulations in renal PT cells. The in vitro experiments properly
identified the cell types examined and allowed a detailed, prop-
erly calibrated examination of the effects of ligands and potential
inhibitors on the PT epithelial cellular calcium levels. Through
the in vivo two-photonmicroscopy studies we could study here-
tofore unexplored features of renal tubular calcium dynamics.
The PT is especially important for nephrotoxicity studies
because active secretion and reabsorption of drugs and metab-
olites occur primarily in these areas. The high energy demand of
these cells makes them especially vulnerable for ischemia. Both
the in vitro and in vivo studies presented here provided impor-
tant information regarding the calcium response of PTE cells to
physiologically relevant ligands, such as ATP and AngII; drugs,
including suramin and candesartan; and pathologic conditions,
especially ischemia-reperfusion–induced renal injury.
Nucleotides have a major role in modifying kidney function
through P2 type receptors.3,27,28 Here we show that ATP
induces a major, temporary calcium increase in renal PTE cells,
followed by desensitization. Pretreatment with suramin, a P2
purinergic receptor inhibitor, eliminated the calcium signal
evoked by ATP both in vitro and in vivo. These findings support
a major calcium response in PTE cells through P2 purinergic
receptors. According to the literature, the major purinergic re-
ceptor types in PTE cells are P2Y1, 2, 4, and 6, as well as P2X4
and 6.29 Exact characterization of the receptor types involved
in the effects of different nucleotides and their specific inhibitors
in PTE cells needs further exploration.
Several physiologic andpathologic kidney responses arebased
on the actionof intrarenal andcirculatingAngII, through specific
receptors both in kidney vessels and PTE cells.30 Indeed, in our
experiments, AngII induced a transient calcium signal in the
renal PTE cells both in vitro and in vivo. This signal most prob-
ably occurred through the activation of the PIP2-IP3 pathway by
the AT1 because short pretreatment with candesartan, a specific
inhibitor of AT1,31 eliminated the AngII-induced calcium re-
sponse (Figure 4C).
In the in vitro studies we examined the effects of several li-
gands and drugs in isolated PTE cells and performed model
experiments for mimicking ischemia and reperfusion. When
applying in vivo two-photon microscopy, we revealed intrarenal
calcium dynamics during physiologic as well as pathologic con-
ditions, including renal ischemia and reperfusion. The live rat
renal PTE cells showed a spontaneous individual oscillation of
the intracellular free calcium concentration. Similar oscillations
consisting two superimposed components were detected by
Peti-Peterdi et al. in proximal and distal tubule cells by loading
with a red calcium fluorophore, Rhod-2 AM.2 It was hypothe-
sized that the slower component of the oscillation originates
MC tonormalmedium (also containing 300 nMKB-R7943). The fluorescencedatawere normalized to a calibrated rangeof cellular calcium
levels (Fmax-Fmin) (see Concise Methods). Data are mean (6SD) of 30 individual cells from three parallel experiments.
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from the tubular fluid flow rates regulated by the tubuloglomer-
ular feedback, while the faster one originates from myogenic
vasoconstriction of the afferent arteriole.
Moreover, despite the relatively homogenous distribution of
GCaMP2 protein in PTE cells, as documented by immunostain-
ing (Figure 1), the in vivo calcium-dependent fluorescence
showed remarkable differences in different cortical PT areas.
The rhodamine filtration experiments suggested that these areas
belong to individual nephrons, and the cellular calcium may re-
flect the activity of nephrons controlled by the tubulo-glomerular
feedback.
In pathologic conditions, including renal transplantation,
ischemia-reperfusion–induced tubular necrosis is a key feature.
PTE cells also represent the major site of injury in various con-
genital, metabolic, and inflammatory diseases.4,5 The mecha-
nisms of the effects of ischemia-reperfusion are not properly
understood yet; thus, identification of endogenous effectors
and their potential pharmacological modu-
lation may significantly aid in therapeutic
interventions. Several studies indicate that
alterations in PTE cell calcium levels have a
central role in these phenomena.3
When following in vivo PT cellular cal-
cium levels by the calcium indicator protein,
we observed remarkable calcium changes
both under ischemia and after reperfusion
of the kidney. Because PT calcium waves
could also be evoked by ATP or AngII, we
examined the potential role of these endog-
enous ligands in this phenomenon. We
found that a general blockade of P2 receptors
did not have a major effect on ischemia-
reperfusion–induced cellular calcium changes
(not shown). In contrast, the selective block-
ade of AT1 significantly decreased the reper-
fusion-induced cellular calcium increase.
AT1 is more abundantly expressed in the
kidney endothelial cells32; thus, the simulta-
neous blockade of these receptors may also
affect PT calcium changes.
Reports in the literature suggest that the
reverse mode of operation of the NCX
protein may be involved in the ischemia-
reperfusion–induced accumulation of cal-
cium in the kidney cortex. PTE cells express
relatively high levels of the high-capacity
NCX (the only other tissue with similar
high-level expression is the cardiac muscle),
normally protecting these cells against a
rapid calcium overload. However, a pro-
longed period of cellular sodium accumula-
tion during ischemia, due to the lower ATP
levels and the decreased functionof theNa-K
pump, may produce Na efflux and Ca influx
through the NCX.33
Our experiments, measuring renal PT calcium changes in
vivo, strongly support the presence of this phenomenon during
reperfusion. Pretreatment of the animal with low concentrations
of the NCX inhibitor KB-R794322 slightly increased and pro-
longed the PT cellular calcium increase during ischemia and
decreased the rapid calcium accumulation after reperfusion,
supposedly by blocking the reverse operation of the NCX. In
these experiments we had to select KB-R7943 concentrations
(,1 mM) not affecting the heart of the animal. Because renal
calcium alterations through voltage-dependent or other calcium
channelsmay also be involved in ischemia-reperfusion,34 further
studies are needed to explore additional pathways.
In summary, the experiments reported here document appli-
cability of the TG rat expressing the GCaMP2 calcium indicator
protein for studying physiologic and pathologic alterations of free
calcium in renal PTE cells. By applying this animal model in
combination with an advanced imaging approach, we provide
Figure 3. In vivo two-photon measurements of the GCaMP2 expressing rat kidneys
show significant heterogeneity in PT basal fluorescence and enable the detection of
spontaneous calcium oscillations in PTE cells. (A) Renal PT basic cellular calcium levels
reflected by GCaMP2 fluorescence in relatively large kidney cortex areas (transgene
animals [TG]). Comparisons were made to control, wild-type (WT) animals. Higher
magnification of PTs of the transgenic rat kidney (GCaMP2 fluorescence, green; nuclei
Hoechst 33342, blue; artificially colored and rhodamine-dextran fluorescence, red). (B)
In vivo calcium oscillations in the neighboring PTE cells with temporally and spatially
variable frequency (Supplemental Video 1). These oscillations are compared with small
changes in fluorescence in the respective cellular areas in the control (WT) animals.
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information for the underlying pathomechanism of ischemia-
reperfusion and its potential pharmacologic modulation.
CONCISE METHODS
The Hungarian Animal Health and Animal Welfare Directorate ap-
provedallanimalprotocolsaccordingtotheEuropeanUnion’sdirectives.
Generation of GCaMP2 Transgene Rats
The DNA fragment encoding GCaMP2 was isolated from the pN1-
GCaMP2plasmid,agenerousgiftof JunichiNakai (RIKENBrainScience
Institute, Saitama, Japan).10 Transgenic rats were derived by microin-
jection of zygotes obtained from superovulated females. To promote
integration and avoid concatemerization of the transgene, the transgene
containing transposonvector was applied as a circular plasmid, together
with the SB1003 transposase mRNA; the latter was necessary to min-
imize mosaicism. The SB transposon vectors integrate into the genome
in a nearly random manner, and the SB1003-mediated transgene
integrations allow the generation of transgenic lines with tissue-specific
expression patterns, specified by promoter elements of choice.9
To establish a rat strain with a single transgene copy per haploid
genome, a combined genotype and phenotype screening procedure was
applied (Szebenyi et al., submitted). Briefly, an outbred stock of the
Sprague-Dawley rat strain was used for the experiments and microinjec-
ted zygotes were implanted into pseudopregnant females. Founder
generation (F0) animals were selected by screening tail tissue–derived
genomic DNAusing SB transposon specific PCR primers. Average trans-
gene copy numbers were determined by a transposon-specific real-time
PCR method.35 Selected founders were crossed with wild-type rats to
generate low-copy-number animals with stable transgene integration
(F1 generation). Rats with single-copy integration were screened for
GCaMP2 expression in blood cells by FACS or were euthanized to mon-
itor GCaMP2 expression level in several target tissues. Transgene carriers
with high expression were crossed with wild-type counterparts (F2 gen-
eration). Single-copy F2 rats were then inbred to generate homozygous
offspring carrying two copy transgenes. In the established rat strain, trans-
gene integration locus was determined by a splinkerette PCR method.16
Figure 4. In vivo GCaMP2 fluorescence changes in the renal proximal tubular cells show the elevation of calcium level after intraarterial
addition of ATP and AngII—these effects are blocked by the respective receptor inhibitors. (A and B) GCaMP2 fluorescence changes
after the intraarterial addition of ATP 3.25 mg/kg (100 mM )—effect of 5-minute pretreatment with suramin 25 mg/kg (300 mM). (C and
D) GCaMP2 fluorescence changes after the intraarterial addition of AngII 50 mg/kg (0.75 mM)—effect of 5-minute pretreatment with 28
mg/kg candesartan (1 mM).
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Tissue Immunohistochemistry
Tissues were frozen in isopentane immediately after dissection and then
cut with a cryostat into 5-mm thin sections. For the detailed staining
protocols see the Supplemental Material. Wild-type tissues were used as
negative controls for GFP staining, and secondary antibody controls
were used to detect nonspecific binding of the secondary antibodies.
Immunohistochemistry images were examined by anOlympus FV500-
IX confocal laser scanning microscope.
Immunocytochemistry
Five-day-old culturesof primarycells isolated fromkidneycortexwere
incubated with 10 mM EGTA for 5 minutes before fixation with
methanol and being washed with PBS. Blocking and immunostaining
were performed as described above for the tissue slices; nuclei were
stainedwithDAPI. Secondary antibody controlswere used, and image
detection was performed as described above.
Generation of Primary PTE Cell Cultures
Primary PTE cell cultures were established from kidney cortex as
described in detail in the SupplementalMaterial. Tubular cells in 500-
ml RPMI were plated onto eight-well Nunc Lab-Tek II Chambered
Coverglass (Nalgen Nunc International, Rochester, NY) covered with
rat collagen (type I solution from rat tail; Sigma-Aldrich, St. Louis,
MO), and culturemediawere changed every second day. The PTE cell
phenotype was routinely verified by monitoring morphology and
g-glutamyl transpeptidase (GGT1/2; Santa Cruz Biotechnology,
Santa Cruz, CA) expression.
In Vitro Confocal Microscopy
For measuring cellular calcium, GCaMP2 expressing primary rat PTE
cells were seeded onto eight-well Nunc Lab-Tek II Chambered Cover-
glass covered by 0.01% collagen solution, type I from rat tail (C3867;
Sigma-Aldrich).Culturemediawas removedbychangingthemediumto
Hanks balanced salt solution. Calcium signals were initiated by various
ligands (see main text and figure legends), and ligand or inhibitor
concentrations were chosen according to the literature. For calibration
procedures, ionomycin 5 mM and then EGTA were used in five times
excess of calcium concentration in the medium.36 To simulate hypoxic
conditions in vitro, CoCl2 200 mMwas added to the cultures in 500-ml
phenol-red free RPMI completed with 3% penicillin/streptomycin, 1%
L-glutamine, and 20% FBS. Calcium signal measurements were carried
out by following time-lapse sequences of cellular fluorescence record-
ings, and imageswere analyzedwith FluoViewTiempo software, version
4.3 (Olympus). For GCaMP2 imaging, cells were excited with the
488-nm laser line and emissionwasmeasured between 505 and 535 nm.
In Vivo Two-Photon Measurements
All in vivo experiments were performed according to the Committee
on the Care and Use of Laboratory Animals of the Council on Animal
Care at the Semmelweis University of Budapest, Hungary (22.1/3491/
003/2008).
For two-photon imaging, the animals were anesthetized with a
combination of ketamine (100 mg/kg) and xylazine (10 mg/kg). The
trachea and the carotid artery were cannulated for stable respiration
and treatment purposes. An incision was made on the left flank of the
animal, and the left kidneywas exteriorized, secured formeasurement,
and placed on a glass coverslip above the objective. The kidneys were
continuously bathed in warm 0.9% saline during the imaging. For
visualization of intrarenal blood flow and the cellular calcium changes
simultaneously, the animalswere treatedwith intraarterial injectionof
Figure 5. In vivo calcium dynamics under ischemia/reperfusion can
be influenced by the AT1 antagonist candesartan and by the NCX
inhibitor KB-R7943, but not by the P2 purinergic receptor inhibitor
suramin. (A and B) Control (bold) lines: Clamping of the renal blood
vessels induces a major calcium peak in the PT cells, slowly de-
creasing to baseline level. Reperfusion (removing the clamp) induces
a second calcium wave. (A) In vivo effect of 5-minute pretreatment
with 28 mg/kg candesartan (1 mM), an AT1 inhibitor, on the PT
calcium levels during ischemia and reperfusion. (B) In vivo effect of
5-minute pretreatment with 8.0 mg/kg KB-R7943 (300 nM), an Na-Ca
exchanger inhibitor, on the PT calcium levels during ischemia
and reperfusion. (C) In vivo effect of 5-minute pretreatment with
25 mg/kg (300 mM) suramin, a P2 purinergic receptor inhibitor, on
the PT calcium levels during ischemia and reperfusion.
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70-kDa rhodamine-dextran (D-1841; Life Technologies, Budapest,
Hungary).
Images and videoswere acquired using a FEMTO2Dhigh-sensitivity
galvanoscanner-based inverted two-photon microscope system
(Femtonics Ltd., Budapest, Hungary). Observations were made using
an UPLSAPO 103 air immersion objective (N.A. 0.4) and UPLSAPO
603 oil immersion objective (N.A. 1.35). Excitation was provided by
Mai Tai DeepSee femtosecond pulsing titanium-sapphire deep see
laser (SpectraPhysics, Mountain View, CA). Images were collected
by two non-descanned photomultiplier tube detectors at two spectral
ranges (490–560 nm and 600–700 nm). For measuring GCaMP2 sig-
nals, an excitation wavelength of 910 nm was used; for the simulta-
neous measurements of rhodamine and GCaMP2 fluorescence, an
excitation wavelength of 850 nm was used. Hoechst was excited at
720 nm. Images and data volumes were processed using the MATLAB-
based MES software (Femtonics Ltd.) and ImageJ software (National
Institutes of Health, Bethesda, MD).
All experiments presented in this paper were performed in at least
three tofive independent tissuepreparations or three tofive transgenic
animals.
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